10 – Interfering with Gene Function at the RNA Level with Oligozymes—the Development of New Tools and Therapeutics

作者: Brian S. Sproat , Shaji T. George , Michael Ma , Allan R. Goldberg

DOI: 10.1016/B978-012233210-4/50011-6

关键词:

摘要: Publisher Summary The hammerhead ribozyme motif, discovered in certain plant pathogens, is a member of small class naturally occurring catalytic ribonucleic acid (RNAs). In nature an intramolecular reaction leads to cis-cleavage; however, it was shown that the motif could be split into two pieces, RNA target sequence and part, cleave trans. Suitable chemical modification has led development oligomers are chemically stable nuclease resistant so they can used cell culture or vivo. Such modified participate sequence-specific cleavage targeted molecule, have been termed oligozymes. The chapter describes classes oligozymes, which one based on ribozymes composed 2'-0-allylribonucleotides. latter analogues possess variety properties render them useful for application molecular biology, notably stability, resistance, strong preference bind over DNA low level nonspecific binding. other oligozyme Innovirs proprietary EGS (External Guide Sequence) technology. oligozymes small, oligonucleotides designed specific sites generate motifs resembling precursor tRNA, cleaved by cellular RNase P.

参考文章(89)
D. Herschlag, M. Khosla, Z. Tsuchihashi, R.L. Karpel, An RNA chaperone activity of non-specific RNA binding proteins in hammerhead ribozyme catalysis The EMBO Journal. ,vol. 13, pp. 2913- 2924 ,(1994) , 10.1002/J.1460-2075.1994.TB06586.X
G. Paolella, B.S. Sproat, A.I. Lamond, Nuclease resistant ribozymes with high catalytic activity. The EMBO Journal. ,vol. 11, pp. 1913- 1919 ,(1992) , 10.1002/J.1460-2075.1992.TB05244.X
Nassim Usman, James A. McSwiggen, Chapter 30. Catalytic RNA (Ribozymes) as Drugs Annual Reports in Medicinal Chemistry. ,vol. 30, pp. 285- 294 ,(1995) , 10.1016/S0065-7743(08)60943-4
O. Heidenreich, F. Benseler, A. Fahrenholz, F. Eckstein, High activity and stability of hammerhead ribozymes containing 2'-modified pyrimidine nucleosides and phosphorothioates Journal of Biological Chemistry. ,vol. 269, pp. 2131- 2138 ,(1994) , 10.1016/S0021-9258(17)42145-4
C J Doersen, C Guerrier-Takada, S Altman, G Attardi, Characterization of an RNase P activity from HeLa cell mitochondria. Comparison with the cytosol RNase P activity. Journal of Biological Chemistry. ,vol. 260, pp. 5942- 5949 ,(1985) , 10.1016/S0021-9258(18)88920-7
H Kijima, Therapeutic applications of ribozymes. Pharmacology & Therapeutics. ,vol. 68, pp. 247- 267 ,(1995) , 10.1016/0163-7258(95)02008-X
O Heidenreich, F Eckstein, Hammerhead ribozyme-mediated cleavage of the long terminal repeat RNA of human immunodeficiency virus type 1. Journal of Biological Chemistry. ,vol. 267, pp. 1904- 1909 ,(1992) , 10.1016/S0021-9258(18)46032-2
T A Garrett, N Gokaldas, L M Pabón-Peña, L M Epstein, Novel requirements in peripheral structures of the extended satellite 2 hammerhead RNA. ,vol. 2, pp. 699- 706 ,(1996)
V Reither, B S Sproat, P L Iversen, M Dunkel, J Ludwig, J P Desjardins, W Gerdes, M Blaschke, T Rupp, B Beijer, Pharmacokinetics of a synthetic, chemically modified hammerhead ribozyme against the rat cytochrome P-450 3A2 mRNA after single intravenous injections. Journal of Pharmacology and Experimental Therapeutics. ,vol. 278, pp. 1419- 1427 ,(1996)